FLT3 BiTE molecules induced T-cell dependent cytotoxicity of FLT3-positive cells in vitro, reduced tumor growth and increased survival in AML mouse models. Both molecules studied exhibited reproducible pharmacokinetic and pharmacodynamic profiles in non-human primates. The gene discussed is FLT3; the disease is neoplasm.